News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results
Photo taken from Georges Gebrael/X
Apr 4, 2024, 20:02

Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results

Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:

“Just in ACS Journal Cancer. Patients with clear cell mRCC kidney cancer from real world Flatiron database status post ICI treatment, similar survival with cabozantinib and ICI vs. cabozantinib monoRx aligning with CONTACT03 trial results.”

Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results

Source: Georges Gebrael/X

 

ACS Journal Cancer Cabozantinib cancer CONTACT03 trial Georges Gebrael ICI ICI treatment kidney cancer OncoDaily Oncology patients
Special Coverage
Blog
Sep 11, 2024, 17:08
Yakup Gözderesi: Huge thanks to my colleagues at WHO Europe as we move forward with Phase VII and Phase VIII
Blog
Sep 11, 2024, 16:56
Coral Olazagasti: Honored to host the official IASLC Lung Cancer Considered podcast
Blog
Sep 11, 2024, 16:47
Chandler Park: Informative talk by Hiba Khan on the PARP inhibitor combination trials
Insight
Sep 11, 2024, 16:34
Andrea Necchi: Our next piece of the neoadjuvant puzzle in muscle-invasive bladder cancer
Blog
Sep 11, 2024, 16:30
Idalid Franco: Prepping for upcoming activities
Blog
Sep 11, 2024, 16:20
Kimryn Rathmell: AllofUsResearch - Changing the future of health research
Insight
Sep 11, 2024, 16:13
RYBREVANT plus LAZCLUZE versus osimertinib in EGFR-mutated advanced lung cancer
Blog
Sep 11, 2024, 15:45
Catherine Mwaba: Serving on the AORTIC Council as VP of Southern Africa is a privilege
Blog
Sep 11, 2024, 14:46
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Blog
Sep 11, 2024, 13:57
Melvin LK Chua on the individualization of systemic therapies with radiotherapy in NPC at ESMO24
Blog
Sep 11, 2024, 13:56
Estela Rodriguez: Celebrating 50 years of IASLC
Blog
Sep 11, 2024, 13:55
Ana I. Velazquez Manana: Who benefits from adjuvant immunotherapy after neoadjuvant chemotherapy plus immunotherapy and surgery